278 related articles for article (PubMed ID: 9664234)
1. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
2. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
Natl Toxicol Program Tech Rep Ser; 2001 Dec; (496):1-352. PubMed ID: 11852482
[TBL] [Abstract][Full Text] [Related]
3. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice.
Voss KA; Riley RT; Bacon CW; Chamberlain WJ; Norred WP
Nat Toxins; 1996; 4(1):16-23. PubMed ID: 8680749
[TBL] [Abstract][Full Text] [Related]
4. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
5. Mycotoxin-induced elevation of free sphingoid bases in precision-cut rat liver slices: specificity of the response and structure-activity relationships.
Norred WP; Plattner RD; Dombrink-Kurtzman MA; Meredith FI; Riley RT
Toxicol Appl Pharmacol; 1997 Nov; 147(1):63-70. PubMed ID: 9356308
[TBL] [Abstract][Full Text] [Related]
6. Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis.
Riley RT; Enongene E; Voss KA; Norred WP; Meredith FI; Sharma RP; Spitsbergen J; Williams DE; Carlson DB; Merrill AH
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):301-8. PubMed ID: 11359699
[TBL] [Abstract][Full Text] [Related]
7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
Soriano JM; González L; Catalá AI
Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
[TBL] [Abstract][Full Text] [Related]
9. Dietary fumonisin B1 induces disruption of sphingolipid metabolism in Sprague-Dawley rats: a new mechanism of nephrotoxicity.
Riley RT; Hinton DM; Chamberlain WJ; Bacon CW; Wang E; Merrill AH; Voss KA
J Nutr; 1994 Apr; 124(4):594-603. PubMed ID: 8145083
[TBL] [Abstract][Full Text] [Related]
10. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
[TBL] [Abstract][Full Text] [Related]
12. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of in-situ apoptosis in mouse liver and kidney after short-term repeated exposure to fumonisin B1.
Sharma RP; Dugyala RR; Voss KA
J Comp Pathol; 1997 Nov; 117(4):371-81. PubMed ID: 9502273
[TBL] [Abstract][Full Text] [Related]
14. Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B(1).
Enongene EN; Sharma RP; Bhandari N; Voss KA; Riley RT
Food Chem Toxicol; 2000 Sep; 38(9):793-9. PubMed ID: 10930700
[TBL] [Abstract][Full Text] [Related]
15. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
Bhandari N; He Q; Sharma RP
Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
[TBL] [Abstract][Full Text] [Related]
16. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
[TBL] [Abstract][Full Text] [Related]
18. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
Turner PC; Nikiema P; Wild CP
Mutat Res; 1999 Jul; 443(1-2):81-93. PubMed ID: 10415433
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides).
Voss KA; Howard PC; Riley RT; Sharma RP; Bucci TJ; Lorentzen RJ
Cancer Detect Prev; 2002; 26(1):1-9. PubMed ID: 12088196
[TBL] [Abstract][Full Text] [Related]
20. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
